Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 238

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease

Poesen, Koen, De Schaepdryver, Maxim, Stubendorff, Beatrice, Gille, Benjamin, Muckova, Petra, Wendler, Sindy, Prell, Tino, Ringer, Thomas M., Rhode, Heidrun, Stevens, Olivier, Claeys, Kristl G., Couwelier, Goedele, D'Hondt, Ann, Lamaire, Nikita, Tilkin, Petra, Van Reijen, Dimphna, Gourmaud, Sarah, Fedtke, Nadin, Heiling, Bianka, Rumpel, Matthias, Rödiger, Annekathrin, Gunkel, Anne, Witte, Otto W., Paquet, Claire, Vandenberghe, Rik, Grosskreutz, Julian, Van Damme, Philip · 2017 · Neurology

Abstract

OBJECTIVE: To determine the diagnostic performance and prognostic value of phosphorylated neurofilament heavy chain (pNfH) and neurofilament light chain (NfL) in CSF as possible biomarkers for amyotrophic lateral sclerosis (ALS) at the diagnostic phase. METHODS: We measured CSF pNfH and NfL concentrations in 220 patients with ALS, 316 neurologic disease controls (DC), and 50 genuine disease mimics (DM) to determine and assess the accuracy of the diagnostic cutoff value for pNfH and NfL and to correlate with other clinical parameters. RESULTS: pNfH was most specific for motor neuron disease (specificity 88.2% [confidence interval (CI) 83.0%-92.3%]). pNfH had the best performance to differentially diagnose patients with ALS from DM with a sensitivity of 90.7% (CI 84.9%-94.8%), a specificity of 88.0% (CI 75.7%-95.5%) and a likelihood ratio of 7.6 (CI 3.6-16.0) at a cutoff of 768 pg/mL. CSF pNfH and NfL levels were significantly lower in slow disease progressors, however, with a poor prognostic performance with respect to the disease progression rate. CSF pNfH and NfL levels increased significantly as function of the number of regions with both upper and lower motor involvement. CONCLUSIONS: In particular, CSF pNfH concentrations show an added value as diagnostic biomarkers for ALS, whereas the prognostic value of pNfH and NfL warrants further investigation. Both pNfH and NfL correlated with the extent of motor neuron degeneration. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that elevated concentrations of CSF pNfH and NfL can accurately identify patients with ALS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000004029

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 238

Metadata

Authors
Poesen, K., De Schaepdryver, M., Stubendorff, B., Gille, B., Muckova, P., Wendler, S., Prell, T., Ringer, T. M., Rhode, H., Stevens, O., Claeys, K. G., Couwelier, G., D'Hondt, A., Lamaire, N., Tilkin, P., Van Reijen, D., Gourmaud, S., Fedtke, N., Heiling, B., Rumpel, M., Rödiger, A., Gunkel, A., Witte, O. W., Paquet, C., Vandenberghe, R., Grosskreutz, J., & Van Damme, P.
Venue
Neurology
Published
2017-06-13
Volume
88
Issue
24
Pages
2302-2309
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2612214304
Cited by
238
References
3
FWCI
14.48
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. https://app.cochat.ai/papers/10.1212/wnl.0000000000004029
The paper
Poesen, K., De Schaepdryver, M., Stubendorff, B., Gille, B., Muckova, P., Wendler, S., Prell, T., Ringer, T. M., Rhode, H., Stevens, O., Claeys, K. G., Couwelier, G., D'Hondt, A., Lamaire, N., Tilkin, P., Van Reijen, D., Gourmaud, S., Fedtke, N., Heiling, B., . . . Van Damme, P. (2017). Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology. https://doi.org/10.1212/wnl.0000000000004029

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.